Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Other Non Operating Income: 2011-2024

Historic Other Non Operating Income for Myriad Genetics (MYGN) over the last 14 years, with Dec 2024 value amounting to $1.1 million.

  • Myriad Genetics' Other Non Operating Income rose 150.00% to $400,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $700,000, marking a year-over-year increase of 600.00%. This contributed to the annual value of $1.1 million for FY2024, which is 125.00% up from last year.
  • According to the latest figures from FY2024, Myriad Genetics' Other Non Operating Income is $1.1 million, which was up 125.00% from -$4.4 million recorded in FY2023.
  • Myriad Genetics' Other Non Operating Income's 5-year high stood at $139.3 million during FY2021, with a 5-year trough of -$4.4 million in FY2023.
  • Moreover, its 3-year median value for Other Non Operating Income was $600,000 (2022), whereas its average is -$900,000.
  • Per our database at Business Quant, Myriad Genetics' Other Non Operating Income skyrocketed by 1,250.00% in 2020 and then crashed by 833.33% in 2023.
  • Over the past 5 years, Myriad Genetics' Other Non Operating Income (Yearly) stood at $16.2 million in 2020, then reached $15.3 million in 2020, then surged by 810.46% to $139.3 million in 2021, then slumped by 99.57% to $600,000 in 2022, then slumped by 833.33% to -$4.4 million in 2023, then soared by 125.00% to $1.1 million in 2024.